Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract

MISSISSAUGA, Ontario — Bora Pharmaceuticals Co., Ltd. (“Bora”; TWSE: 6472; OTCQX: BORAY), a global leader in pharmaceutical manufacturing, and GSK (LSE/NYSE: GSK) have signed a strategic agreement to renew a five-year manufacturing partnership. Bora purchased the Mississauga facility from GSK in 2020. This renewed collaboration reinforces the long-standing relationship between the two companies and expands the partnership, allowing GSK access to multiple sites within the Bora network, including its newest oral solid dose (OSD) site in Maple Grove, Minnesota. Read More

S&P 500 Falls on Tariff Questions, Nvidia Gains Before Earnings

(Bloomberg) — US stocks traded lower on Monday as President Donald Trump responded to the Supreme Court’s ruling against his sweeping tariffs by imposing a new, across-the-board 15% levy on US imports, sowing fresh confusion around global trade. Shares of Nvidia Corp. were a bright spot, advancing before Wednesday’s earnings report. Read More